JavaScript is disabled in your browser. Please enable JavaScript to view this website.

RASGRP2

Developmental stage

Expressed in fetal brain, lung, liver and kidney.

Domain

The N-terminal Ras-GEF domain mediates association with F-actin.

Function

Functions as a calcium- and DAG-regulated nucleotide exchange factor specifically activating Rap through the exchange of bound GDP for GTP. May also activate other GTPases such as RRAS, RRAS2, NRAS, KRAS but not HRAS. Functions in aggregation of platelets and adhesion of T-lymphocytes and neutrophils probably through inside-out integrin activation. May function in the muscarinic acetylcholine receptor M1/CHRM1 signaling pathway.

Involvement in disease

Bleeding disorder, platelet-type, 18

BDPLT18

A disorder characterized by increased bleeding tendency due to platelet dysfunction. Clinical features include epistaxis, hematomas, bleeding after tooth extraction, and menorrhagia.

None

The disease is caused by variants affecting the gene represented in this entry.

Post-translational modifications

Isoform 2 is palmitoylated and myristoylated.

Sequence Similarities

Belongs to the RASGRP family.

Tissue Specificity

Detected in platelets, neutrophils and T lymphocytes (at protein level). Expressed in brain where it is enriched in the striatum. Also expressed in the hematopoietic system. Detected in heart, brain, lung, placenta, liver, skeletal muscle and kidney.

Cellular localization

Alternative names

CDC25L, MCG7, RASGRP2, RAS guanyl-releasing protein 2, Calcium and DAG-regulated guanine nucleotide exchange factor I, Cdc25-like protein, F25B3.3 kinase-like protein, CalDAG-GEFI, hCDC25L

swissprot:Q7LDG7 entrezGene:10235 omim:605577